- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Mnemo Therapeutics S.A.S.
BioCentury | Jul 31, 2024
Management Tracks
Murray joins Bioluminescence
Plus: Terns names Elona Kogan chief legal officer, and updates from AiCuris and Anaveon
BioCentury | Oct 7, 2023
Management Tracks
New CEO for Asceneuron
Plus: Genentech veteran Hegde heads to Kite and more from ARTbio, Takeda, Anebulo and MMRF
BioCentury | Mar 28, 2023
Management Tracks
Calithera’s Kuriakose to head oncology at Terns
Plus: Christine Foster named CBO at hC, and updates from Meliora, Seismic and ClavystBio
BioCentury | Mar 24, 2023
Product Development
Landscape of emerging T cell therapies in cancer
Four axes of risk map how companies founded in the last five years are innovating in CAR T and TCR T cells
BioCentury | Jan 21, 2023
Discovery & Translation
Epigenome editing for X-linked diseases; plus a rapid platform for human mAb generation and more
BioCentury’s roundup of translational news
BioCentury | Dec 15, 2022
Management Tracks
Debra Yu leaving LianBio
Plus: Bayer vet Weinand appointed chair at Umoja, and updates from vTv, Gradalis, Generate and more
BioCentury | Dec 1, 2022
Management Tracks
Gasal to be CMO at Anaveon
Plus Anderson joins Centessa and updates from Mnemo and NXI
BioCentury | Feb 24, 2022
Management Tracks
Philip to succeed Marrazzo at Spark
Plus LaCaze joins Mnemo and updates from Sumitomo, Veracyte, Totus and more
BioCentury | Jan 15, 2022
Discovery & Translation
HLA-independent TCRs with increased antigen sensitivity; plus Synthekine, Luminary and more
BioCentury’s roundup of translational news
Items per page:
1 - 9 of 9